{"success":true,"data":{"pressRelease":{"id":"47883","rtpr_id":"nGNX7qJ2wl","ticker":"ORKA","exchange":"NASDAQ","all_tickers":["ORKA"],"title":"Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference","author":"Globe Newswire","published_at":"2026-05-28T12:00:03.822Z","article_body":"MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc.\n(“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company\ndeveloping novel biologics designed to set a new standard for the treatment of\nchronic skin diseases including plaque psoriasis, today announced its\npresentation at the 2026 Jefferies Global Healthcare Conference, taking place\nin New York, NY from June 2-4, 2026.\n\nPresentation Details\nDate: Wednesday, June 3(rd), 2026\nPresentation Time: 3:45PM ET\n\nA webcast and replay of Oruka’s presentations will be available on the Oruka\ninvestor events website at\nhttps://ir.orukatx.com/news-events/events-presentations.\n\nAbout Oruka Therapeutics\nOruka Therapeutics is developing novel biologics designed to set a new\nstandard for the treatment of chronic skin diseases. Oruka’s mission is to\noffer patients suffering from chronic skin diseases like plaque psoriasis the\ngreatest possible freedom from their condition by achieving high rates of\ncomplete disease clearance with dosing as infrequently as once or twice a\nyear. Oruka is advancing a proprietary portfolio of potentially best-in-class\nantibodies that target the core mechanisms underlying plaque psoriasis and\nother dermatologic and inflammatory diseases. For more information, visit\nwww.orukatx.com and follow Oruka on LinkedIn.\n\nInvestor Contact: \nAlan Lada \n(650)-606-7911 \nalan.lada@orukatx.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/3950d2d7-850d-459a-9e42-07c642a841c5)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX7qJ2wl","title":"Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference","author":"Globe Newswire","ticker":"ORKA","created":"2026-05-28T12:00:03.822Z","tickers":["ORKA"],"exchange":"NASDAQ","article_body":"MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc.\n(“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company\ndeveloping novel biologics designed to set a new standard for the treatment of\nchronic skin diseases including plaque psoriasis, today announced its\npresentation at the 2026 Jefferies Global Healthcare Conference, taking place\nin New York, NY from June 2-4, 2026.\n\nPresentation Details\nDate: Wednesday, June 3(rd), 2026\nPresentation Time: 3:45PM ET\n\nA webcast and replay of Oruka’s presentations will be available on the Oruka\ninvestor events website at\nhttps://ir.orukatx.com/news-events/events-presentations.\n\nAbout Oruka Therapeutics\nOruka Therapeutics is developing novel biologics designed to set a new\nstandard for the treatment of chronic skin diseases. Oruka’s mission is to\noffer patients suffering from chronic skin diseases like plaque psoriasis the\ngreatest possible freedom from their condition by achieving high rates of\ncomplete disease clearance with dosing as infrequently as once or twice a\nyear. Oruka is advancing a proprietary portfolio of potentially best-in-class\nantibodies that target the core mechanisms underlying plaque psoriasis and\nother dermatologic and inflammatory diseases. For more information, visit\nwww.orukatx.com and follow Oruka on LinkedIn.\n\nInvestor Contact: \nAlan Lada \n(650)-606-7911 \nalan.lada@orukatx.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/3950d2d7-850d-459a-9e42-07c642a841c5)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-28T12:00:03.855855989Z","server_sent_at_ms":1779969603855},"received_at":"2026-05-28T12:00:04.119Z","source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302782/0/en/Oruka-Therapeutics-to-Present-at-the-2026-Jefferies-Global-Healthcare-Conference.html"},"analysis":{"id":"37315","press_release_id":"47883","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Oruka Therapeutics will present at the 2026 Jefferies Global Healthcare Conference in New York.\n\nThe presentation is scheduled for Wednesday, June 3, 2026, at 3:45 PM ET.\n\nA webcast and replay will be available on the company's investor events website.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference appearance; no new data disclosed."},"keyFigures":{},"quotedText":"Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced its presentation at the 2026 Jefferies Global Healthcare Conference","namedEntities":{"people":[{"name":"Alan Lada","role":"Investor Contact"}],"products":[],"companies":[{"name":"Oruka Therapeutics, Inc.","ticker":"ORKA"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine conference presentation announcement. No new clinical data, partnership, or financial disclosure is included in this release."},"tickerRelevance":{"others":[],"primary":"ORKA"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"conference-presentation","sectorWeight":"biotech","householdBrandBoost":0}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Oruka Therapeutics will present at the 2026 Jefferies Global Healthcare Conference in New York.\n\nThe presentation is scheduled for Wednesday, June 3, 2026, at 3:45 PM ET.\n\nA webcast and replay will be available on the company's investor events website.","key_figures":{},"named_entities":{"people":[{"name":"Alan Lada","role":"Investor Contact"}],"products":[],"companies":[{"name":"Oruka Therapeutics, Inc.","ticker":"ORKA"},{"name":"Jefferies","relationship":"conference organizer"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-28T12:16:20.206Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"conference-presentation","sectorWeight":"biotech","householdBrandBoost":0}},"durationMs":null,"modelName":"george-droid-qwen-72b"}}